Evidence map›Paper›PMID 15018647›Full record

ArticleBMC genomics2004

Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons.

Katleen De Preter, Filip Pattyn, Geert Berx, Kristin Strumane, Björn Menten, Frans Van Roy, Anne De Paepe, Frank Speleman, Jo Vandesompele

Abstract read
In one paragraph

Article in BMC genomics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katleen De PreterCenter for Medical Genetics, Ghent University Hospital 1K5, De Pintelaan 185, 9000 Gent, Belgium. katleen.depreter@ugent.be
Filip Pattyn
Geert Berx
Kristin Strumane
Björn Menten
Frans Van Roy
Anne De Paepe
Frank Speleman
Jo Vandesompele

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivation of proto-oncogenes by DNA amplification is an important mechanism in the development and maintenance of cancer cells. Until recently, identification of the targeted genes relied on labour intensive and time consuming positional cloning methods. In this study, we outline a straightforward and efficient strategy for fast and comprehensive cloning of amplified and overexpressed genes.

resultsAs a proof of principle, we analyzed neuroblastoma cell line IMR-32, with at least two amplification sites along the short arm of chromosome 2. In a first step, overexpressed cDNA clones were isolated using a PCR based subtractive cloning method. Subsequent deposition of these clones on a custom microarray and hybridization with IMR-32 DNA, resulted in the identification of clones that were overexpressed due to gene amplification. Using this approach, amplification of all previously reported amplified genes in this cell line was detected. Furthermore, four additional clones were found to be amplified, including the TEM8 gene on 2p13.3, two anonymous transcripts, and a fusion transcript, resulting from 2p13.3 and 2p24.3 fused sequences.

conclusionsThe combinatorial strategy of subtractive cDNA cloning and array CGH analysis allows comprehensive amplicon dissection, which opens perspectives for improved identification of hitherto unknown targeted oncogenes in cancer cells.

Indexed as

Cell Line, TumorChromosomes, Human, Pair 2Cloning, MolecularDEAD-box RNA HelicasesDNADNA, ComplementaryFemaleGene AmplificationGene Expression ProfilingHomeodomain ProteinsHumansIn Situ Hybridization, FluorescenceMaleMyeloid Ecotropic Viral Integration Site 1 ProteinNeoplasm ProteinsN-Myc Proto-Oncogene ProteinDDX1 protein, humanDEAD-box RNA HelicasesDNADNA, ComplementaryHomeodomain ProteinsMYCN protein, humanMyeloid Ecotropic Viral Integration Site 1 ProteinNBAS protein, humanNeoplasm ProteinsN-Myc Proto-Oncogene ProteinNuclear ProteinsOncogene ProteinsRNA HelicasesRNA, Messenger

Identifiers

PMID15018647
PMCPMC365025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.